Refractory Acute Myeloid Leukemia — Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia
Citation(s)
A Pilot Study of Targeted Daunorubicin Dosing to Overcome Chemotherapeutic Resistance in Children With Relapsed or Refractory Acute Leukemia